Sionna Therapeutics (SION) Shares Issued (2024 - 2025)
Quarterly results put Shares Issued at $200.1 million for Q4 2025, up 800264.0% from a year ago — trailing twelve months through Mar 2026 was -$318000.0 (down 100.16% YoY), and the annual figure for FY2025 was $202.1 million, up 143212.77%.
Sionna Therapeutics has reported Shares Issued over the past 2 years, most recently at $200.1 million for Q4 2025.
- Shares Issued reached $200.1 million in Q4 2025 per SION's latest filing, up from -$200.1 million in the prior quarter.
- Across five years, Shares Issued topped out at $202.4 million in Q1 2025 and bottomed at -$200.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 163.10 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Sionna Therapeutics | 1.87 Bn | 1.87 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 200.09 Mn |
| Dec 31, 2025 | 200.09 Mn |
| Sep 30, 2025 | -200.09 Mn |
| Sep 30, 2025 | -200.09 Mn |
| Jun 30, 2025 | -318,000.00 |
| Jun 30, 2025 | -318,000.00 |
| Mar 31, 2025 | 202.39 Mn |
| Mar 31, 2025 | 202.39 Mn |
| Dec 31, 2024 | 25,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 116,000.00 |
| Sep 30, 2024 | 116,000.00 |